These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1412056

  • 1. Analysis of high dysmorphogenic activity of Ro 13-6307, a tetramethylated tetralin analog of retinoic acid.
    Kochhar DM, Penner JD.
    Teratology; 1992 Jun; 45(6):637-45. PubMed ID: 1412056
    [Abstract] [Full Text] [Related]

  • 2. Retinamides: hydrolytic conversion of retinoylglycine to retinoic acid in pregnant mice contributes to teratogenicity.
    Kochhar DM, Shealy YF, Penner JD, Jiang H.
    Teratology; 1992 Feb; 45(2):175-85. PubMed ID: 1615427
    [Abstract] [Full Text] [Related]

  • 3. Placental transfer and developmental effects of 9-cis retinoic acid in mice.
    Kochhar DM, Jiang H, Penner JD, Heyman RA.
    Teratology; 1995 Apr; 51(4):257-65. PubMed ID: 7570368
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic assessment of teratologically effective concentrations of an endogenous retinoic acid metabolite.
    Satre MA, Penner JD, Kochhar DM.
    Teratology; 1989 Apr; 39(4):341-8. PubMed ID: 2749577
    [Abstract] [Full Text] [Related]

  • 5. Induction of RAR-beta 2 gene expression in embryos and RAR-beta 2 transactivation by the synthetic retinoid Ro 13-6307 correlates with its high teratogenic potency.
    Soprano DR, Tairis N, Gyda M, Harnish DC, Jiang H, Soprano KJ, Kochhar DM.
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):159-63. PubMed ID: 8397452
    [Abstract] [Full Text] [Related]

  • 6. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223.
    Willhite CC, Lovey A, Eckhoff C.
    Toxicol Appl Pharmacol; 2000 Apr 15; 164(2):171-5. PubMed ID: 10764630
    [Abstract] [Full Text] [Related]

  • 7. Structure-toxicity relationships of the tetramethylated tetralin and indane analogs of retinoic acid.
    Howard WB, Willhite CC, Sharma RP.
    Teratology; 1987 Dec 15; 36(3):303-11. PubMed ID: 3424219
    [Abstract] [Full Text] [Related]

  • 8. Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenesis bioassays.
    Kochhar DM, Penner JD, Minutella LM.
    Drug Metab Dispos; 1989 Dec 15; 17(6):618-24. PubMed ID: 2575497
    [Abstract] [Full Text] [Related]

  • 9. Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit.
    Collins MD, Tzimas G, Bürgin H, Hummler H, Nau H.
    Toxicol Appl Pharmacol; 1995 Jan 15; 130(1):9-18. PubMed ID: 7839374
    [Abstract] [Full Text] [Related]

  • 10. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
    Tzimas G, Nau H, Hendrickx AG, Peterson PE, Hummler H.
    Teratology; 1996 Nov 15; 54(5):255-65. PubMed ID: 9035347
    [Abstract] [Full Text] [Related]

  • 11. Comparative disposition, receptor affinity, and teratogenic activity of sulfon arotinoids.
    Willhite CC, Dubois A, Schindler-Horvat J, Apfel C, Eckhoff C.
    Teratology; 1995 Sep 15; 52(3):169-75. PubMed ID: 8638257
    [Abstract] [Full Text] [Related]

  • 12. Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (Ro 13-7410): binding affinities and disposition.
    Pignatello MA, Kauffman FC, Levin AA.
    Toxicol Appl Pharmacol; 1997 Feb 15; 142(2):319-27. PubMed ID: 9070355
    [Abstract] [Full Text] [Related]

  • 13. Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits.
    Eckhoff C, Chari S, Kromka M, Staudner H, Juhasz L, Rudiger H, Agnish N.
    Toxicol Appl Pharmacol; 1994 Mar 15; 125(1):34-41. PubMed ID: 8128493
    [Abstract] [Full Text] [Related]

  • 14. The role of RXR-alpha in retinoic acid-induced cleft palate as assessed with the RXR-alpha knockout mouse.
    Nugent P, Sucov HM, Pisano MM, Greene RM.
    Int J Dev Biol; 1999 Sep 15; 43(6):567-70. PubMed ID: 10610030
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endogenous distribution of retinoids during normal development and teratogenesis in the mouse embryo.
    Horton C, Maden M.
    Dev Dyn; 1995 Mar 15; 202(3):312-23. PubMed ID: 7780180
    [Abstract] [Full Text] [Related]

  • 18. Differential teratogenic response of mouse embryos to receptor selective analogs of retinoic acid.
    Kochhar DM, Jiang H, Penner JD, Beard RL, ChandraratnaAS.
    Chem Biol Interact; 1996 Mar 08; 100(1):1-12. PubMed ID: 8599851
    [Abstract] [Full Text] [Related]

  • 19. Amelioration of embryotoxicity by structural modification of the terminal group of cancer chemopreventive retinoids.
    Willhite CC, Shealy YF.
    J Natl Cancer Inst; 1984 Mar 08; 72(3):689-95. PubMed ID: 6583452
    [Abstract] [Full Text] [Related]

  • 20. Skeletal morphogenesis: comparative effects of a mutant gene and a teratogen.
    Kochhar DM.
    Prog Clin Biol Res; 1985 Mar 08; 171():267-81. PubMed ID: 3157194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.